Why Do I Need A Lawyer 

70 drug companies sued in Alabama for Medicaid drug fraud

70 drug companies sued in Alabama for Medicaid drug fraud

Alabama asks for $800M from GSK, Novartis By tracy Created Jul 1 2008 - 9:30am

Alabama attorney general stuck an $800 million suggested price on its Medicaid fraud case against GlaxoSmithKline and Novartis. In closing arguments yesterday, the state asked jurors for that multimillion-dollar award as repayment for the drugmakers\' alleged overcharging for Medicaid drugs--and to send a message to other pharma firms. \"We won\'t tolerate a reimbursement shell game,\" the lead prosecutor said.

According to the state, GSK and Novartis charged the Medicaid program more for meds than they did other customers from 1991 to 2005. Medicaid is supposed to get the drugmakers\' lowest offered price.

The companies, however, say they\'ve done nothing wrong.

According to Novartis\'s attorney, the federal government requires drugmakers to report list prices that don\'t include discounts. \"It is not fair to punish Novartis for doing what the federal government says for us to do,\" he said.

The two drugmakers are among 70 companies sued in Alabama for Medicaid drug fraud, and this is the second case to go to trial. In February, a jury told AstraZeneca to pay $215 million to the state, but Judge Charles Price, who\'s also presiding over this second trial, lowered the award to $160 million.

originally Published on FiercePharma (http://www.fiercepharma.com) - read the Associated Press article -Medicaid drug fraud

Read Related Articles: AZ to appeal $215M Alabama judgment [1] Drug companies must pay for Medicare pricing scheme [2] Judge upholds AZ fraud verdict [3]

Videos

Drug Company Lawsuit News

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation ... - MarketWatch (press release)

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation ... MarketWatch (press release) The Company's product pipeline includes Dimebon -- also known by its generic name, latrepirdine -- a drug being developed as a treatment for ... and more »

Read more...

---

State joins antipsychotic drug lawsuit - Boston Globe

State joins antipsychotic drug lawsuit Boston Globe The lawsuit against Johnson & Johnson — filed in January by the US attorney in Boston, Carmen M. Ortiz — alleges that the drug company paid millions to ... J&J Pushed Risperdal for Elderly After US Warning, Files ShowBloomberg Did J&J Plan to Break Rules?BusinessWeek all 5 news articles »

Read more...

---

Vineland woman at centre of birth control suit - Hamilton Spectator

CBC.ca

Vineland woman at centre of birth control suit Hamilton Spectator A Vineland mother is the face of a Canadian class action against the Bayer pharmaceutical company over what the lawsuit says were inadequate warnings on the ... Bayer Accused in Canadian Lawsuit of Hiding Yaz RisksBusinessWeek Woman sues drug maker over birth control pillSt. Catharines Standard all 24 news articles »

Read more...

---

Turning Off the Phone After 20 Years on Call - New York Times (blog)

Turning Off the Phone After 20 Years on Call New York Times (blog) The lawsuit was filed against NBC Universal, Universal Studios and Universal Pictures Company. Universal Pictures bought the photo from a stock agency, ... and more »

Read more...

---

Robbins Umeda LLP Announces Investigation of Medivation, Inc. - MarketWatch (press release)

Robbins Umeda LLP Announces Investigation of Medivation, Inc. MarketWatch (press release) A lawsuit alleging violations of the Securities Exchange Act of 1934 has been filed on behalf of shareholders who purchased or otherwise acquired Medivation ... Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been ...CNNMoney.com (press release) Medivation Class Action Has Questionable RootsBloggingStocks (blog) Kendall Law Group Plans Class Action on Behalf of Medivation, Inc. ShareholdersPharmaLive.com (press release) all 45 news articles »

Read more...

---

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ... - MarketWatch (press release)

Novelos Therapeutics Believes Class Action Lawsuit is without Merit and ... MarketWatch (press release) ... competition from other pharmaceutical companies, product pricing and third-party reimbursement. Novelos Therapeutics, Inc. COMPANY Harry S. Palmin, ... and more »

Read more...

---

Holzer Holzer & Fistel, LLC Announces That a Shareholder Class Action Lawsuit ... - CNNMoney.com (press release)

Holzer Holzer & Fistel, LLC Announces That a Shareholder Class Action Lawsuit ... CNNMoney.com (press release) ... complied with the fiduciary duties they owed to the Company and its shareholders in connection with the conduct alleged in the class action lawsuit. ... and more »

Read more...

---